GNMX Holdings
Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF
1W: -0.7%
1M: +5.9%
YTD: +4.2%
$37.73
+0.38 (+1.03%)
Weekly Expected Move ±3.8%
$35
$36
$38
$39
$41
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$2M
Holdings57
Top 10 Wt47.1%
Beta2.27
% Profitable27%
Coverage96%
Portfolio Valuation
P/E44.0
P/B5.9
P/S7.5
EV/EBITDA30.9
P/FCF42.9
PEG7.09
Profitability & Returns
Gross Margin52.4%
Net Margin9.7%
ROE7.4%
ROA4.0%
ROIC6.9%
Div Yield0.15%
Leverage & Liquidity
Debt/Equity0.61
Debt/Assets0.31
Net Debt/EBITDA1.6x
Interest Cov5.1x
Current Ratio2.14
Quick Ratio1.79
Growth (YoY)
Revenue+14.5%
Net Income+6.1%
EPS+10.9%
FCF+16.7%
EBITDA+19.1%
Rev CAGR 3Y+44.2%
Quality Scores
Piotroski F4.8
Altman Z7.48
IS Quality57.4
IS Overall48.0
IS Value39.4
Median P/E-6.8
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 55 | 95.2% | -4.8 |
| Other | 2 | 2.5% | — |
| Technology | 2 | 2.3% | -29.7 |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 50 of 59 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific Inc | TMO | 8.46% | $243,018 | 360 | 35.2 | $242.1B | Healthcare |
| 2 | Moderna Inc | MRNA | 8.35% | $239,750 | 1,245 | -23.8 | $75.4B | Healthcare |
| 3 | Vertex Pharmaceuticals Inc | VRTX | 5.74% | $164,685 | 315 | 29.1 | $128.1B | Healthcare |
| 4 | Illumina Inc | ILMN | 4.72% | $135,472 | 495 | 50.5 | $41.3B | Healthcare |
| 5 | 10X Genomics Inc | TXG | 3.82% | $109,787 | 1,215 | -158.5 | $11.9B | Healthcare |
| 6 | Guardant Health Inc | GH | 3.63% | $104,341 | 585 | -50.9 | $23.9B | Healthcare |
| 7 | Revolution Medicines Inc | RVMD | 3.32% | $95,446 | 465 | -23.3 | $43.9B | Healthcare |
| 8 | Iovance Biotherapeutics Inc | IOVA | 3.15% | $90,476 | 6,105 | -20.3 | $6.3B | Healthcare |
| 9 | Twist Bioscience Corp | TWST | 3.13% | $89,857 | 465 | -85.0 | $11.7B | Healthcare |
| 10 | Genmab A/S | GMAB | 2.83% | $81,339 | 2,280 | 26.5 | $21.3B | Healthcare |
| 11 | Incyte Corp | INCY | 2.66% | $76,450 | 630 | 14.2 | $23.4B | Healthcare |
| 12 | Alnylam Pharmaceuticals Inc | ALNY | 2.58% | $74,022 | 300 | 36.0 | $29.4B | Healthcare |
| 13 | First American Government Obligations Fund 12/01/2031 Swap | — | 2.49% | $71,373 | 71,373 | — | — | — |
| 14 | GRAIL Inc | GRAL | 2.20% | $63,054 | 450 | -14.7 | $6.1B | Healthcare |
| 15 | Bio-Techne Corp | TECH | 2.08% | $59,788 | 825 | 61.9 | $11.3B | Healthcare |
| 16 | Tempus AI Inc | TEM | 2.01% | $57,740 | 705 | -53.6 | $13.4B | Healthcare |
| 17 | BioMarin Pharmaceutical Inc | BMRN | 1.97% | $56,700 | 945 | 150.5 | $11.1B | Healthcare |
| 18 | CareDx Inc | CDNA | 1.83% | $52,650 | 810 | 31.2 | $3.5B | Healthcare |
| 19 | Adaptive Biotechnologies Corp | ADPT | 1.78% | $51,153 | 1,770 | -69.6 | $4.5B | Healthcare |
| 20 | QIAGEN NV | QGEN | 1.78% | $51,199 | 1,170 | 22.9 | $9.2B | Healthcare |
| 21 | Krystal Biotech Inc | KRYS | 1.74% | $49,884 | 150 | 39.0 | $9.5B | Healthcare |
| 22 | Schrodinger Inc/United States | SDGR | 1.48% | $42,383 | 1,365 | -41.0 | $2.3B | Technology |
| 23 | NeoGenomics Inc | NEO | 1.40% | $40,208 | 2,190 | -9.3 | $475M | Healthcare |
| 24 | Arrowhead Pharmaceuticals Inc | ARWR | 1.40% | $40,252 | 615 | -28.7 | $9.0B | Healthcare |
| 25 | CRISPR Therapeutics AG | CRSP | 1.36% | $39,001 | 705 | -11.6 | $5.3B | Healthcare |
| 26 | Caris Life Sciences Inc | CAI | 1.28% | $36,756 | 1,200 | 76.1 | $8.0B | Healthcare |
| 27 | Veracyte Inc | VCYT | 1.27% | $36,602 | 795 | 31.8 | $3.7B | Healthcare |
| 28 | Ideaya Biosciences Inc | IDYA | 1.24% | $35,731 | 930 | -19.5 | $3.6B | Healthcare |
| 29 | Absci Corp | ABSI | 1.22% | $35,056 | 3,255 | -13.8 | $1.9B | Healthcare |
| 30 | Personalis Inc | PSNL | 1.21% | $34,676 | 2,130 | -14.9 | $1.7B | Healthcare |
| 31 | Ionis Pharmaceuticals Inc | IONS | 1.12% | $32,148 | 720 | -12.6 | $7.2B | Healthcare |
| 32 | Nurix Therapeutics Inc | NRIX | 1.11% | $32,008 | 1,350 | -6.7 | $2.4B | Healthcare |
| 33 | Relay Therapeutics Inc | RLAY | 0.95% | $27,346 | 1,515 | -12.1 | $4.2B | Healthcare |
| 34 | Recursion Pharmaceuticals Inc | RXRX | 0.91% | $26,267 | 6,360 | -4.0 | $2.2B | Healthcare |
| 35 | uniQure NV | QURE | 0.86% | $24,643 | 1,020 | -5.8 | $1.6B | Healthcare |
| 36 | Beam Therapeutics Inc | BEAM | 0.82% | $23,472 | 960 | -29.9 | $2.5B | Healthcare |
| 37 | Azenta Inc | BRKS | 0.82% | $23,551 | 675 | -18.4 | $7.8B | Technology |
| 38 | Sarepta Therapeutics Inc | SRPT | 0.80% | $22,957 | 1,260 | -12.2 | $1.8B | Healthcare |
| 39 | Certara Inc | CERT | 0.79% | $22,770 | 2,475 | -21.1 | $1.5B | Healthcare |
| 40 | Castle Biosciences Inc | CSTL | 0.78% | $22,384 | 630 | -53.9 | $1.1B | Healthcare |
| 41 | GeneDx Holdings Corp | WGS | 0.76% | $21,690 | 300 | -20.1 | $2.2B | Healthcare |
| 42 | 4D Molecular Therapeutics Inc | FDMT | 0.71% | $20,392 | 1,425 | -5.0 | $715M | Healthcare |
| 43 | Intellia Therapeutics Inc | NTLA | 0.67% | $19,356 | 1,605 | -3.6 | $1.7B | Healthcare |
| 44 | Pacific Biosciences of California Inc | PACB | 0.66% | $18,913 | 7,980 | -5.9 | $789M | Healthcare |
| 45 | Generate Biomedicines Inc | GENB | 0.66% | $18,925 | 1,260 | -12.9 | $1.8B | Healthcare |
| 46 | Biodesix Inc | BDSX | 0.65% | $18,793 | 630 | -8.7 | $226M | Healthcare |
| 47 | Sophia Genetics SA | SOPH | 0.62% | $17,724 | 2,115 | -7.0 | $677M | Healthcare |
| 48 | Fulgent Genetics Inc | FLGT | 0.54% | $15,524 | 705 | -7.6 | $610M | Healthcare |
| 49 | Ultragenyx Pharmaceutical Inc | RARE | 0.53% | $15,331 | 1,020 | -2.6 | $1.5B | Healthcare |
| 50 | Arcturus Therapeutics Holdings Inc | ARCT | 0.51% | $14,785 | 1,080 | -3.9 | $370M | Healthcare |